Haiti, Science, & Me: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Haiti, Science, & Me.

Press releases published on October 5, 2026

Phunware to Present and Host One-on-One Meetings at the LD Micro 20th Annual Main Event on Tuesday, October 20, 2026
AIB Data Centers to Present and Host One-on-One Meetings at the LD Micro 20th Annual Main Event on Wednesday, October 21, 2026
EM&T to Host Operational Showcase of the Largest High-Performance Rare Earth Magnet Facility in Production Outside China on December 17, 2026, Anchoring Expansion to 10,000+ Metric Tons of Annual Capacity
Worldwide NFT, Inc. Announces Hiring of Finn Dunne as VP of M&A
Leonardo DRS Establishes UK Subsidiary and Launches Local Capabilities for its Tactical Radars including Full Manufacturing
Duos Technologies Sells Its GPU-as-a-Service Entity to Axe Compute, Accelerating Its Shift to a Pure-Play AI Colocation Platform
Aprea Therapeutics to Present at October Conferences
Axe Compute Takes Full Ownership of Georgia AI Cluster, Significantly Increasing the Contract’s Expected Free Cash Flow and Gross Margin
Autolus Therapeutics to Present Longer-Term Follow Up Data from CARLYSLE Trial at the American College of Rheumatology Convergence 2026
SAIC Acquires Information Security Corporation, Expanding Zero-Trust, Post-Quantum Cryptography and Encryption Capability
Zorronet Ltd. Announces Joint Framework Agreement with Tier 1 Israeli IT Integrator
Music Industry Community Brings Music, Networking, and Industry Connections to Chase Bell and LIRA’s “Do Me” Live Experience
Orion Pharma announces first patient dosed in Phase 1/2 clinical trial of ODM-216, the company’s first biologic candidate to reach clinical testing
Ensimmäinen potilas on saanut hoitoa Orion Pharman Faasi 1/2 -tutkimuksessa ODM-216-molekyylillä, joka on yhtiön ensimmäinen kliiniseen kehitysvaiheeseen edennyt biologinen syöpälääkeaihio
PDAOAI Opens BIO REBOOT Collaboration and Showcases Partitioned Literature Aggregation at Drug Discovery 2026
PMV Pharmaceuticals Appoints Matt Eckler, Ph.D., to Board of Directors
Gate Bioscience Expands Collaboration and License Agreement with Lilly to Target Difficult-to-Drug Proteins
4DMT to Host Investor Day on October 21, 2026
Revolution Medicines Begins Treating Patients in Phase 3 RASolute 309 Trial Evaluating RASONQUE™ (daraxonrasib) Plus Zoldonrasib as First-Line Treatment for Metastatic RAS G12D Pancreatic Cancer
Cerevance Appoints Karl Kieburtz, M.D., M.P.H., as Chief Medical Officer

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Haiti, Science, & Me

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.